Identification and management of tuberculosis

American Family Physician

Volumn 61, Issue 9, 2000, Pages 2667-2678

  Jerant, Anthony F ^a   Bannon, Michelle ^b   Rittenhouse, Stephen ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PROTEINASE INHIBITOR; PYRAZINAMIDE; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STREPTOMYCIN;

ARTHRALGIA; ARTICLE; BLEEDING; DISEASE TRANSMISSION; DRUG RESISTANCE; GASTROINTESTINAL SYMPTOM; HEPATITIS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERURICEMIA; OPTIC NERVE DISEASE; PATIENT COMPLIANCE; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ALGORITHMS; ANTITUBERCULAR AGENTS; CHILD; HIV INFECTIONS; HUMANS; ISONIAZID; PATIENT COMPLIANCE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0034193993     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. McCray E, Weinbaum CM, Braden CR, Onorato IM. The epidemiology of tuberculosis in the United States. Clin Chest Med 1997;18:99-113.
2. Tuberculosis morbidity - United States, 1997. MMWR Morb Mortal Wkly Rep 1998;47:253-6.
3. American Thoracic Society/Centers for Disease Control and Prevention Committee on Latent Tuberculosis Infection. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med [In press].
4. Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1995; 44:19-34.
5. Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 1997;278:304-7.
6. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998;338:1641-9 [Published erratum appears in N Engl J Med 1998;339:139].
7. Correa AG. Unique aspects of tuberculosis in the pediatric population. Clin Chest Med 1997;18:89-98.
8. McDermott LJ, Glassroth J, Mehta JB, Dutt AK. Tuberculosis. Part I. Dis Mon 1997;43:113-80.
9. Kendig EL, Kirkpatrick BV, Carter WH, Hill FA, Caldwell K, Entwistle M. Underreading of the tuberculin skin test reaction. Chest 1998;113:1175-7.
10. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Morb Mortal Wkly Rep 1994; 43:1-132.
11. McColloster P, Neff NE. Outpatient management of tuberculosis. Am Fam Physician 1996;53:1579-94.
12. TB care guide: highlights from Core Curriculum on Tuberculosis. Atlanta: U.S. Dept. of Health and Human Services, Public Health Services, Centers for Disease Control and Prevention, National Center for Prevention Services, Division of Tuberculosis Elimination, 1994:19-26.
13. Comstock GW. How much isoriazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999;3:847-50.
14. American Academy of Pediatrics Committee on Infectious Diseases. Chemotherapy for tuberculosis in infants and children. Pediatrics 1992;89:161-5.
15. Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1995;44:1-16.
16. El-Sohl A, Mylotte J, Sherif S, Serghani J, Grant BJ. Validity of a decision tree for predicting active pulmonary tuberculosis. Am J Respir Crit Care Med 1997;155:1711-6 [Published erratum appears in Am J Respir Crit Care Med 1997;156:2028].
17. Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis 1993;17:968-75.
18. McAdams HP, Erasmus J, Winter JA. Radiologic manifestations of pulmonary tuberculosis. Radiol Clin North Am 1995;33:655-78.
19. Post FA, Wood R, Pillay GP. Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count. Tuber Lung Dis 1995; 76:518-21.
20. LoBue PA, Catanzaro A, Dutt AK, Stead W. Tuberculosis. Part II. Dis Mon 1997;43:181-274.
21. Finch D, Beaty CD. The utility of a single sputum specimen in the diagnosis of tuberculosis. Comparison between HIV-infected and non-HIV-infected patients. Chest 1997;111:1174-9.
22. Levy H, Feldman C, Sacho H, van der Meulen H, Kallenbach J, Koornhof H. A reevaluation of sputurn microscopy and culture in the diagnosis of pulmonary tuberculosis. Chest 1989;95:1193-7.
23. Barnes PF. Rapid diagnostic tests for tuberculosis: progress but no gold standard [Editorial]. Am J Respir Crit Care Med 1997;155:1497-8 [Published erratum appears in Am J Respir Crit Care Med 1997;156(3 pt 1):1022].
24. de Blic J, Azevedo I, Burren CP, LeBourgeois M, Lallemand D, Scheinmann P. The value of flexible bronchoscopy in childhood pulmonary tuberculosis. Chest 1991;100:688-92.
25. Georgia TB reference guide. Atlanta: Atlanta Tuberculosis Prevention Coalition, 1998:24-5. Retrieved February 23, 2000, from the World Wide Web: http://www.ph.dhr.state.ga.us/epi/manuals/ pdf/tbguide99.pdf.
26. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 1998; 47:1-58.
27. Bradford WZ, Daley CL. Multiple drug-resistant tuberculosis. Infect Dis Clin North Am 1998;12: 157-72.
28. Pomerantz M, Brown JM. Surgery in the treatment of multidrug-resistant tuberculosis. Clin Chest Med 1997;18:123-30.
29. Miller KS, Miller JM. Tuberculosis in pregnancy: interactions, diagnosis, and management. Clin Obstet Gynecol 1996;39:120-42.
30. Snider DE, Powell KE. Should women taking anti-tuberculous drugs breast-feed? Arch Intern Med 1984;144:589-90.
31. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis. Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA 1998;279:943-8 [Published erratum appears in JAMA 1998;280:134].
32. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 1997;111:1168-73.
33. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995;274:945-51.
34. Oscherwitz T, Tulsky JP, Roger S, Sciortino S, Alpers A, Royce S, et al. Detention of persistently nonadherent patients with tuberculosis. JAMA 1997;278:843-6.
35. Burman WJ, Dalton CB, Cohn DL, Butler JR, Reves RR. A cost-effectiveness analysis of directly observed therapy vs. self-administered therapy for treatment of tuberculosis. Chest 1997;112:63-70.
36. Institutional control measures for tuberculosis in the era of multiple drug resistance. ACCP/ATS Consensus Conference. American College of Chest Physicians and the American Thoracic Society. Chest 1995;108:1690-1710.
37. Sumarlojo E, Geiter L, Miller B, Hale B. Can physicians treat tuberculosis? Report on a national survey of physician practices. Am J Public Health 1997:87:2008-11.